Plato Investment Management »

Neurocrine Biosciences shares owned by Plato Investment Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Plato Investment Management from 13F filings

Historical chart of Plato Investment Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Plato Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Plato Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $41k 295 137.92

More positions owned by Plato Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Broadcom (AVGO)
Visa (V)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Abbvie (ABBV)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Procter & Gamble Company (PG)

View all positions for Plato Investment Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Jpmorgan Chase & Co
Renaissance Technologies
Morgan Stanley
Bellevue Group
T. Rowe Price Associates
Geode Capital Management
Henderson Group
Dodge & Cox
Invesco
DSM Capital Partners
Brown Advisory Holdings Incorporated
Pictet Asset Management Holding SA

View all funds holding Neurocrine Biosciences